The COVID-19 pandemic has disrupted the world like few events before it. But for Shukun Technology, a response required "a minor change in our strategy," according to its chief technology officer, Chao Zheng. That's because Shukun, a startup founded by some of China's brightest AI and medical minds, was busy refining its AI-powered platform to diagnose heart disease and strokes when the global pandemic struck. The company quickly shifted resources to develop a system that analyzes chest CT scans to help speed up diagnoses of COVID-19 patients. That system, called Lung Doc – pneumonia edition, has already been rolled out to 30 hospitals in China over the past few months, where it will grow more accurate as it learns from more data.